Vident Investment Advisory, LLC Shattuck Labs, Inc. Transaction History

Vident Investment Advisory, LLC

  • $0
  • Q3 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$8.36 - $21.08 $421,026 - $1.06 Million
-50,362 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$17.57 - $28.95 $63,216 - $104,162
-3,598 Reduced 6.67%
50,362 $1.03 Million
Q2 2021

Aug 13, 2021
BUY
$24.14 - $37.68 $1.3 Million - $2.03 Million
53,960 New
53,960 $1.56 Million

Others Institutions Holding STTK

# of Institutions
79
Shares Held
28.6M
Call Options Held
300
Put Options Held
1.2K
View Full List

About Shattuck Labs, Inc.

STTK Quotes by TradingView
  • Ticker STTK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,382,000
  • Market Cap $51.3M
  • Description
  • Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...
More about STTK
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email